Saturday, 22 August 2020

Novartis Immuno-oncology Drug Candidate Fails Skin Cancer Trial

Swiss drugmaker Novartis said on Saturday that its investigational spartalizumab immunooncology drug mixed with the approved medicines Tafinlar and Mekinist failed in a latestage trial for a type of advanced skin cancer.

from Top Business News- News18.com https://ift.tt/31lzcBn
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Beyond Borders: The True Origins Of India's Favorite Brands - Colgate, Bata And Maruti

Bata grew into one of the world's leading shoemakers, with an impressive annual sale of 150 million pairs of shoes across more than 70 c...